Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance, Multiple, Bacterial”

109 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 109 results

Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Not applicableStudy completedNCT04383106
What this trial is testing

Bowel Colonization With Multi-drug Resistant Bacterial Species in Hospitalized Patients With acute-on Chronic Liver Failure (ACLF), and Its Relationship With Extra-intestinal Infectious Events and Short-term Outcomes.

Who this might be right for
Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 150
Early research (Phase 1)Study completedNCT03910673
What this trial is testing

Intravenous Fosfomycin Pharmacokinetics Study

Who this might be right for
Bacterial InfectionMultiple-drug ResistancePathogen Resistance
National Institute of Allergy and Infectious Diseases (NIAID) 39
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Looking for participantsNCT04759001
What this trial is testing

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 52
Not applicableLooking for participantsNCT06738771
What this trial is testing

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas InfectionsPseudomonas AeruginosaPrognosis+3 more
Centre Hospitalier Régional d'Orléans 600
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Post-approval studies (Phase 4)Study completedNCT03830671
What this trial is testing

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Beijing Chest Hospital 515
Testing effectiveness (Phase 2)Study completedNCT00664313
What this trial is testing

TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
Centers for Disease Control and Prevention 36
Not applicableStudy completedNCT04812847
What this trial is testing

Multidrug Resistant Gram-negative Pathogen Infections in High Risk Neonates in the Northeast of Mexico

Who this might be right for
Infant Newborn Disease
Instituto Tecnologico y de Estudios Superiores de Monterey 597
Not applicableUnknownNCT05833282
What this trial is testing

Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU

Who this might be right for
Drug Resistance, Multiple, Bacterial
Tourcoing Hospital 500
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Testing effectiveness (Phase 2)Study completedNCT00425113
What this trial is testing

Metronidazole for Pulmonary Tuberculosis (South Korea)

Who this might be right for
TuberculosisMulti-Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 35
Testing effectiveness (Phase 2)Study completedNCT02365623
What this trial is testing

An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Janssen Pharmaceutical K.K. 6
Not applicableNot Yet RecruitingNCT07505446
What this trial is testing

Characterization of the Synergistic Antibacterial Effect of Verapamil on Bacterial Isolates From Cancer Patients

Who this might be right for
Multi Drug Resistant OrganismsAntibiotic Resistance
Assiut University 100
Not applicableUnknownNCT03409315
What this trial is testing

Feasibility of Centralized Therapeutic Drug Monitoring of Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis, Multidrug-Resistant
University Medical Center Groningen 360
Large-scale testing (Phase 3)Study completedNCT04207112
What this trial is testing

Economic Evaluation of New MDR TB Regimens

Who this might be right for
Multi-drug Resistant TuberculosisExtensively Drug-Resistant TuberculosisPulmonary Tuberculoses
Medecins Sans Frontieres, Netherlands 73
Post-approval studies (Phase 4)Study completedNCT00495339
What this trial is testing

MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
Sanofi 100
Load More Results